The IMMEDIATE (Immediate Metabolic Myocardial Enhancement During Initial Assessment and Treatment in Emergency Care) Trial is a NIH National Heart, Lung, Blood Institute sponsored study that is testing whether giving an Intravenous (IV) solution of readily available medications (Glucose, Insulin and potassium), referred to as “GIK” is helpful to patients at the first signs of a heart attack.